Talaris Therapeutics Email Format
Biotechnology ResearchKentucky, United States11-50 Employees
Talaris Therapeutics is a biotechnology research company based in Louisville, Kentucky, United States. The company has 11 to 50 employees, indicating a small-to-mid-sized operation. It historically operated commercial-scale cell and gene therapy development and manufacturing facilities in Louisville and Houston. In 2023, the company participated in significant corporate actions, including a reverse merger with Tourmaline Bio and later acquisition events involving Tourmaline and NY Blood Center Enterprises. Financial data reported for the company includes revenue in the range of $1 million to $10 million and total funding of $115 million.